No Data
No Data
Mangoceuticals Issues Bonus Shares to Leadership
Mangoceuticals Slips 25% As It Secures Licensing And Distribution Rights For Diabetinol
Mangoceuticals Secures Exclusive Rights for Plant-Based Nutriceutical Diabetinol to Address Pre-Diabetes and Weight Management Market in U.S. and Canada
Mangoceuticals Expands Into $33 Billion Addressable Diabetes Market Through Its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Mangoceuticals | 10-K: FY2024 Annual Report